Bisphosphonates to reduce bone mets
I’d like to share something that I’ve learned from my oncologist. Bisphosphonates are used to reduce bone density loss in people who are being treated with AI for estrogen receptive breast cancer. O...
Forum Discussion
The 'jury is still out' about the efficacy of denosumab (Prolia) reducing the risk of bone mets, here's a link to recent review and analysis from the American Society of Clinical Oncology (ASCO):
https://ascopost.com/issues/june-25-2019/denosumab-prevents-neither-breast-cancer-relapse-nor-death/
https://ascopost.com/issues/june-25-2019/denosumab-prevents-neither-breast-cancer-relapse-nor-death/